Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
| Image |  |
|---|---|
| Description | scientific article published on 15 March 2010 |
| Author/s |
author: Mikko A I Keränen Rainer Krebs Karl B Lemström Kari Alitalo Bronislaw Pytowski Seppo Ylä-Herttuala |
| Publication date | March 15, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |